For instance: APOE ε4 carriers are more likely to develop AD; toxic Aβ production and deposition is more abundant in APOE ε4 carriers; and APOE ε4 exacerbates Aβ-related neurotoxicity [84]. This evidence concerns the gene APOE and Alzheimer disease.